Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Leapfrog Group, Joint Commission recognize Overlake Medical Center's efforts to improve patient care

Two leading, national organizations focused on improving safety and quality in America's hospitals have recognized Overlake Medical Center efforts to improve care for patients.

6 Nov 2013

Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced third quarter 2013 financial results.

5 Nov 2013

Endocrine Society announces winners of organization's prestigious 2014 Laureate Awards

The Endocrine Society today announced it has selected 15 accomplished endocrinologists as winners of the organization's prestigious 2014 Laureate Awards.

5 Nov 2013

High pneumonia incidence ups elderly COPD medical costs

Older individuals with chronic obstructive pulmonary disease are almost six times more likely to develop pneumonia and eight times more likely to need hospital treatment than those without the disease, US researchers have found.

5 Nov 2013

Insomnia concerns go unaddressed in heart failure patients

The impact of insomnia on health and function is a major concern for patients with heart failure, qualitative and quantitative research shows.

5 Nov 2013

Ambulatory BP best for assessing diabetes CV risk

Ambulatory blood pressure monitoring should be used to monitor patients with Type 2 diabetes who have a high risk for developing cardiovascular complications, say researchers.

5 Nov 2013

Thomas Jefferson University's Department of Medicine named Comprehensive Hypertension Center

The Department of Medicine at Thomas Jefferson University has been named a Comprehensive Hypertension Center by the American Society of Hypertension (ASH). Jefferson is one of only five in the country to earn top recognition for its advanced diagnosis, evaluation and treatment of complex hypertension and associated disorders.

4 Nov 2013

Three Johns Hopkins Medicine hospitals named 2012 Top Performers on Key Quality Measures

The Joint Commission is naming three Johns Hopkins Medicine hospitals as 2012 Top Performers on Key Quality Measures, a designation reserved for accredited hospitals that consistently and at a very high level follow best practices for treating people who require surgery or suffer heart attacks, heart failure, stroke, pneumonia or other serious conditions.

4 Nov 2013

Heart failure patients may benefit from advanced treatment by heart specialists

New research from Karolinska Institutet in Sweden shows that patients with heart failure have high mortality and often are undertreated. According to a study, published in the scientific periodical JACC, many more of these patients would benefit from advanced treatment by heart specialists - something that could be decided by a simple evaluation of five common risk factors for early death due to heart failure.

4 Nov 2013

Current percutaneous techniques shed light on treatment of heart valve leakage

A Paravalvular regurgitation, or leakage, commonly affects valvular prostheses, particularly artificial valves placed percutaneously according to data presented at the 2013 Transcatheter Cardiovascular Therapeutics (TCT) conference.

4 Nov 2013

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

ARIAD Pharmaceuticals, Inc. today announced that it is temporarily suspending the marketing and commercial distribution of Iclusig® (ponatinib), a treatment for patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL), in the United States, while it continues to negotiate updates to the U.S. prescribing information for Iclusig and implementation of a risk mitigation strategy.

31 Oct 2013

Multidisciplinary team tests innovative heart failure therapy in global clinical trials

A multidisciplinary team of experts in heart failure, cardiac arrhythmia, and neurosurgery at The Mount Sinai Hospital are now testing nerve stimulation in the neck as a novel therapy for heart failure patients to potentially help relieve their debilitating symptoms of fatigue, shortness of breath, and heart arrhythmias, while reducing their hospitalizations.

30 Oct 2013

Cvrx closes additional $12 million under its Series F financing

CVRx, Inc., a privately held medical device company, has closed on an additional $12 million under its Series F financing. This brings the total raised in the Series F financing to $42 million.

30 Oct 2013

COMMONWELL project established to support health and social care services

Across Europe, providing health and social care services is becoming increasingly complex and costly. An aging population, a multitude of public, private and informal actors, together with a myriad of e-health systems and technologies create numerous hurdles to offering efficient and cost-effective care.

30 Oct 2013

The Joint Commission names HNMC as ‘Top Performer on Key Quality Measures for 2012’

Holy Name Medical Center (HNMC) was named one of the nation's Top Performers on Key Quality Measures for 2012 by The Joint Commission, the leading accreditor of healthcare organizations in America.

30 Oct 2013

3Sbio acquires patents for DJ5 to delay hereditary renal disease in ADPKD patients

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announced the acquisition of patents for DJ5, a novel non-TZD PPARgamma agonist with potential to retard progressive renal failure in patients with autosomal dominant polycystic kidney disease ("ADPKD').

29 Oct 2013

Beta-blockers increase risk of adverse cardiac event during noncardiac surgical procedure

A recent study shows that patients given beta-blockers may actually be at increased risk of having an adverse cardiac event during a noncardiac surgical procedure. Risk of irregular heartbeat and worsening of symptoms in patients with existing heart disease also seemed to increase, but to a lesser degree.

29 Oct 2013

Study affirms safety profile of Boston Scientific's Vessix System for resistant hypertension

Patients treated with the Boston Scientific Vessix Renal Denervation System experienced a significant and sustained reduction in blood pressure, according to new data presented today at the Transcatheter Cardiovascular Therapeutics Conference in San Francisco.

29 Oct 2013

Middle Peak Medical raises additional $3M in Series A financing

Middle Peak Medical, a development-stage medical device company that will commercialize a novel technology for treating mitral valve disease, has raised an additional $3M in a second closing of its over-subscribed Series A financing, which now totals approximately $11M.

28 Oct 2013

Study examines role of urate-lowering therapy on renal function in patients with hyperuricemia

Urate-lowering therapy alone may not directly reduce the risk of kidney disease in those with hyperuricemia. However, according to a study presented at the American College of Rheumatology Annual Meeting in San Diego, working to lower serum uric acid based on the 2012 American College of Rheumatology Guidelines for Management of Gout has a positive effect.

28 Oct 2013

Heart Failure News and Research

Further Reading

Leapfrog Group, Joint Commission recognize Overlake Medical Center's efforts to improve patient care

Cumberland Pharmaceuticals net revenue decreases from $12.5 to $6.5 million

Endocrine Society announces winners of organization's prestigious 2014 Laureate Awards

High pneumonia incidence ups elderly COPD medical costs

Insomnia concerns go unaddressed in heart failure patients

Ambulatory BP best for assessing diabetes CV risk

Thomas Jefferson University's Department of Medicine named Comprehensive Hypertension Center

Three Johns Hopkins Medicine hospitals named 2012 Top Performers on Key Quality Measures

Heart failure patients may benefit from advanced treatment by heart specialists

Current percutaneous techniques shed light on treatment of heart valve leakage

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

Multidisciplinary team tests innovative heart failure therapy in global clinical trials

Cvrx closes additional $12 million under its Series F financing

COMMONWELL project established to support health and social care services

The Joint Commission names HNMC as ‘Top Performer on Key Quality Measures for 2012’

3Sbio acquires patents for DJ5 to delay hereditary renal disease in ADPKD patients

Beta-blockers increase risk of adverse cardiac event during noncardiac surgical procedure

Study affirms safety profile of Boston Scientific's Vessix System for resistant hypertension

Middle Peak Medical raises additional $3M in Series A financing

Study examines role of urate-lowering therapy on renal function in patients with hyperuricemia

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News